These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 26665263)

  • 1. Manifestation of psoriasis in the oral cavity.
    Fatahzadeh M
    Quintessence Int; 2016 Mar; 47(3):241-7. PubMed ID: 26665263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral psoriasis.
    Bruce AJ; Rogers RS
    Dermatol Clin; 2003 Jan; 21(1):99-104. PubMed ID: 12622272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psoriasis with oral manifestations.
    Cataldo E; McCarthy P; Yaffee H
    Cutis; 1977 Dec; 20(6):705-8. PubMed ID: 590035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral psoriasis-a diagnostic dilemma: a report of two cases and a review of the literature.
    Mattsson U; Warfvinge G; Jontell M
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2015 Oct; 120(4):e183-9. PubMed ID: 25944682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral lesions in patients with psoriasis: clinical presentation and management.
    Brice DM; Danesh-Meyer MJ
    J Periodontol; 2000 Dec; 71(12):1896-903. PubMed ID: 11156048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clobetasol propionate spray 0.05% for the treatment of moderate to severe plaque psoriasis.
    Menter A
    Cutis; 2012 Feb; 89(2):89-94. PubMed ID: 22474733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inflammatory linear verrucous epidermal nevus (ILVEN) and psoriasis in a child?
    Menni S; Restano L; Gianotti R; Boccardi D
    Int J Dermatol; 2000 Jan; 39(1):30-2. PubMed ID: 10651962
    [No Abstract]   [Full Text] [Related]  

  • 8. Clobetasol propionate spray 0.05% add-on therapy to a stable regimen of biologic treatment in patients with moderate to very severe plaque psoriasis.
    Feldman SR; Koo JY; Johnson LA; Preston NJ
    Cutis; 2009 Oct; 84(4 Suppl):25-32. PubMed ID: 19916299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The efficacy of short-term clobetasol lotion in the treatment of scalp psoriasis.
    Rajabi-Estarabadi A; Hasanzadeh H; Taheri A; Feldman SR; Firooz A
    J Dermatolog Treat; 2018 Mar; 29(2):111-115. PubMed ID: 28609161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy, safety, and cost-effectiveness of all-trans retinoic acid/Clobetasol Propionate Compound Ointment in the treatment of mild to moderate psoriasis vulgaris: A randomized, single-blind, multicenter clinical trial.
    Xia L; Li R; Wang Y; Lin Z; Zheng J; Li X; Lu Q; Zhang J; Jin H; Fu L; Zhang X; Liu Y; Yang S; Xiao F; Gao XH
    Dermatol Ther; 2018 Sep; 31(5):e12632. PubMed ID: 30253049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of nail psoriasis with topical application of clobetasol propionate 0.05% solution: a pilot study.
    Brandi N; Starace M; Alessandrini A; Bruni F; Piraccini BM
    Eur J Dermatol; 2018 Feb; 28(1):111-112. PubMed ID: 29336322
    [No Abstract]   [Full Text] [Related]  

  • 12. Randomized double-blind clinical trial comparing clobetasol and dexamethasone for the topical treatment of symptomatic oral chronic graft-versus-host disease.
    Noce CW; Gomes A; Shcaira V; Corrêa ME; Moreira MC; Silva Júnior A; Gonçalves LS; Garnica M; Maiolino A; Torres SR
    Biol Blood Marrow Transplant; 2014 Aug; 20(8):1163-8. PubMed ID: 24727333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Duration of improvement in psoriasis after treatment with tazarotene 0.1% gel plus clobetasol propionate 0.05% ointment: comparison of maintenance treatments.
    Lebwohl M; Lombardi K; Tan MH
    Int J Dermatol; 2001 Jan; 40(1):64-6. PubMed ID: 11277960
    [No Abstract]   [Full Text] [Related]  

  • 14. Unusual palatal presentation of oral psoriasis.
    Richardson LJ; Kratochvil FJ; Zieper MB
    J Can Dent Assoc; 2000 Feb; 66(2):80-2. PubMed ID: 10730005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clobetasol propionate followed by calcipotriol is superior to calcipotriol alone in topical treatment of psoriasis.
    Austad J; Bjerke JR; Gjertsen BT; Helland S; Livden JK; Morken T; Mørk NJ
    J Eur Acad Dermatol Venereol; 1998 Jul; 11(1):19-24. PubMed ID: 9731961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Halobetasol 0.01%/Tazarotene 0.045% Lotion in the Treatment of Moderate-to-Severe Plaque Psoriasis: Maintenance of Therapeutic Effect After Cessation of Therapy.
    Pariser DM; Green LJ; Stein Gold L; Sugarman JL; Lin T; Pillai R
    J Drugs Dermatol; 2018 Jul; 17(7):723-726. PubMed ID: 30005093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The efficacy and tolerability of clobetasol propionate foam 0.05% in the treatment of mild to moderate plaque-type psoriasis of nonscalp regions.
    Gottlieb AB; Ford RO; Spellman MC
    J Cutan Med Surg; 2003; 7(3):185-92. PubMed ID: 12704534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improvement in signs and symptoms of plaque psoriasis after 1 week of treatment with clobetasol propionate 0.05% spray.
    Brodell R; Preston N
    J Drugs Dermatol; 2012 Dec; 11(12):1455-9. PubMed ID: 23377516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The diagnosis and treatment of discoid lupus erythematosus with oral manifestations only: a case report.
    Brown RS; Flaitz CM; Hays GL; Trejo PM
    Compendium; 1994 Jun; 15(6):724, 726-8, 730 passim; quiz 734. PubMed ID: 7994728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of 0.25% zinc pyrithione spray does not enhance the efficacy of clobetasol propionate 0.05% foam in the treatment of psoriasis.
    Housman TS; Keil KA; Mellen BG; McCarty MA; Fleischer AB; Feldman SR
    J Am Acad Dermatol; 2003 Jul; 49(1):79-82. PubMed ID: 12833013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.